Optimal quality of cancer care is crucial for best outcomes. This is especially true for patients suffering from testicular germ cell tumors. These patients are very young, some- times adolescent, usually healthy and cure rates indepen- dent of stage of the disease in industrialized countries approach 97%. With these figures, testicular germ cell tumors present a role model for a curable cancer. The life expectancy of patients in early stages with local treatment followed by active surveillance is not limited compared to the general population. In patients with metastatic disease tumor recurrences do not impact on the life expectancy either since most of the recurrences are curable as well. However, in metastatic patients, the long-term sequelae of the initial systemic treatment like secondary malignancies and life-threatening long-term toxicities due to cisplatin meanwhile represent the most frequent causes of death 30 and more years after end of treatment.
展开▼
